pLV-hUV6-sgRNA-dCas9-KRAB-TagBFP2 (identifier AAAA-0244)
(Plasmid
#202553)
-
PurposeNontargeting control vector with TagBFP2
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 202553 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLV hU6-sgRNA hUbC-dCas9-KRAB-T2a-Puro
-
Backbone manufacturerCharles Gersbach
- Backbone size w/o insert (bp) 14900
- Total vector size (bp) 15002
-
Modifications to backbonePuromycin-resistance gene in the pLV hU6-sgRNA hUbC-dCas9-KRAB-T2a-Puro construct (dCAS9-KRAB; a gift from Charles Gersbach, Addgene plasmid #71236;http://n2t.net/addgene:71236; RRID: Addgene_71236), was replaced by the TagBFP2 (tag blue fluorescent protein 2) marker, which was PCR-amplified from the ACE2 g1 + Cas9 plasmid (a gift from Jason Sheltzer, Addgene plasmid #153011; http://n2t.net/addgene:153011; RRID:Addgene_153011).
-
Vector typeLentiviral, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHumanized dCas9-KRAB-TagBFP2 (tag blue fluorescent protein 2)
-
SpeciesS. Pyogenes (dCas9), H. sapiens (KRAB), Entacmaea quadricolor (TagBFP2)
-
Insert Size (bp)6216
-
MutationPuromycin-resistance gene in the pLV hU6-sgRNA hUbC-dCas9-KRAB-T2a-Puro construct (dCAS9-KRAB; a gift from Charles Gersbach, Addgene plasmid #71236;http://n2t.net/addgene:71236; RRID: Addgene_71236), was replaced by the TagBFP2 (tag blue fluorescent protein 2) marker, which was PCR-amplified from the ACE2 g1 + Cas9 plasmid (a gift from Jason Sheltzer, Addgene plasmid #153011; http://n2t.net/addgene:153011; RRID:Addgene_153011).
-
Entrez GeneTRIM28 (a.k.a. KAP1, PPP1R157, RNF96, TF1B, TIF1B, TIF1beta)
-
Tag
/ Fusion Protein
- 3xFlag (N-terminus of Cas9-KRAB), T2A-TagBFP2
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDr Konstantin Kogan from DNA Dream Lab (DDL) facility (HiLIFE, Institute of Biotechnology, Helsinki, Finland).
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLV-hUV6-sgRNA-dCas9-KRAB-TagBFP2 (identifier AAAA-0244) was a gift from Frederic Meunier (Addgene plasmid # 202553 ; http://n2t.net/addgene:202553 ; RRID:Addgene_202553) -
For your References section:
Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry. Joensuu M, Syed P, Saber SH, Lanoue V, Wallis TP, Rae J, Blum A, Gormal RS, Small C, Sanders S, Jiang A, Mahrhold S, Krez N, Cousin MA, Cooper-White R, Cooper-White JJ, Collins BM, Parton RG, Balistreri G, Rummel A, Meunier FA. EMBO J. 2023 Jul 3;42(13):e112095. doi: 10.15252/embj.2022112095. Epub 2023 May 25. 10.15252/embj.2022112095 PubMed 37226896